NCT06684639
- Conditions
- Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- The General Hospital of Western Theater Command Chengdu, Sichuan, China
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,310 public trials
520 recruiting studies
Recurrence trial results
Recruiting
VHAG in Treating R/R T-ALL/LBL
NCT06742463
- Conditions
- Acute T Lymphpblastic Leukemia/Lymphoma, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT06561854
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Service d'hématologie clinique et thérapie cellulaire, Saint-Antoine Hospital Paris, France
NCT06737250
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Kosin University Gospel Hospital Busan, South Korea
- Chonnam National University Hwasun Hospital Hwasun, South Korea
- Korea National Cancer Center Ilsan, South Korea
- Seoul National University Bundang Hospital Seongnam, South Korea
Recruiting
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
NCT06016920
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
- Locations
-
- Fakultni nemocnice Olomouc, Olomuoc Olomouc, Czechia
- Hôpital de la Pitié - Salpétrière in Paris Paris, France
- Hospices Civils De Lyon Lyon, France
- CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM) Montpellier, France
Recruiting
CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
NCT06735495
- Conditions
- B-Cell Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +19 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
NCT06732232
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- China, Shanghai Mengchao Cancer Hospital Shanghai, China
NCT05934513
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China
NCT06730659
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
NCT06718270
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
- Locations
-
- Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China